Position in CLDX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$39,962,979
+$6,354,564 QoQ
Shares Held
1,073,985
+1.4% QoQ
Ownership
1.37%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#17
of 252 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 90%
Shared 6%
None 4%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,868 across 230 Biotechnology names. CLDX ranks #40 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in CLDX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,962,979 | 1,073,985 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $33,608,415 | 1,059,534 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $17,700,604 | 651,716 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,650,736 | 257,083 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,928,079 | 143,886 | Shares | Sole | 2025-08-12 | |
| 2024-03-31 | $1,822,798 | 43,431 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $9,140,477 | 230,471 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $9,393,951 | 341,350 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $15,391,800 | 453,634 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $17,945,166 | 498,754 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $22,332,956 | 501,076 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $15,025,215 | 534,515 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $16,496,067 | 611,872 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $20,175,713 | 592,358 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $17,372,428 | 449,597 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $19,362,649 | 358,634 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $12,019,138 | 359,424 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $6,249,051 | 303,352 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $5,394,670 | 307,915 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $4,570,502 | 308,193 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $3,987,399 | 306,723 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $574,220 | 345,916 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||